Graham Capital Management’s Biohaven BHVN Stock Holding History

Graham Capital Management’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$298K	Sell	20,056 -35,343	-64%	-$380K	0.01%	898
2026 Q1	$469K	Sell	55,399 -90,453	-62%	-$990K	0.01%	645
2025 Q4	$1.65M	Buy	145,852 +112,228	+334%	+$1.39M	0.04%	272
2025 Q3	$505K	Sell	33,624 -85,669	-72%	-$1.25M	0.01%	608
2025 Q2	$1.68M	Buy	+119,293	New	+$2.13M	0.03%	413
2024 Q3	–	Sell	-6,334	Closed	-$220K	–	1109
2024 Q2	$220K	Buy	+6,334	New	+$250K	﹤0.01%	836
2023 Q4	–	Sell	-8,240	Closed	-$214K	–	1012
2023 Q3	$214K	Buy	+8,240	New	+$171K	0.01%	836

Other funds holding BHVN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

IAM

Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Graham Capital Management's BHVN Position: Q2 2026 in Review

Graham Capital Management reduced its Biohaven (BHVN) stake by 64% in Q2 2026, selling an estimated $380K and leaving 20,056 shares worth $298K. The position accounts for 0.01% of the portfolio, ranked #898.

Graham Capital Management first reported a position in BHVN in Q3 2023 and has held it in 7 quarters since. The position peaked at $1.68M in Q2 2025. 292 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

Graham Capital Management held 20,056 shares of Biohaven worth $298K as of Q2 2026.
Graham Capital Management sold 35,343 Biohaven shares in Q2 2026, an estimated $380K.
Biohaven made up 0.01% of Graham Capital Management's portfolio in Q2 2026, its #898 holding.
Graham Capital Management first reported a position in Biohaven in Q3 2023 and has held it in 7 quarters since.
Graham Capital Management's Biohaven position peaked at $1.68M in Q2 2025.
292 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Graham Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.